Eone Diagnomics Genome Center Co., Ltd operates in the genetic research and development industry, offering genome testing, research development, and IT software services. The company has developed unique genetic analytics technologies for accurate medical and personalized medicine, including cancer diagnosis and prevention. Eone Diagnomics Genome Center claims to be a global leader in genome business and has worked on global projects with influential BT and IT companies.

Headquarters
4F, 291, Harmony-Ro, Yeonsu-Gu, Incheon
Incheon; Incheon;

Contact Details: Purchase the Eone Diagnomics Genome Center Co.,Ltd. report to view the information.

Website: http://www.edgc.com

Basic Information

Total Employees:

Purchase the Eone Diagnomics Genome Center Co.,Ltd. report to view the information.

Outstanding Shares:

Purchase the Eone Diagnomics Genome Center Co.,Ltd. report to view the information.

Registered Capital:

Purchase the Eone Diagnomics Genome Center Co.,Ltd. report to view the information.

Financial Auditors:

Purchase the Eone Diagnomics Genome Center Co.,Ltd. report to view the information.

Incorporation Date:

May 06, 2013

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Ownership Details

Purchase this report to view the information.

10.2%

Purchase this report to view the information.

8.3%

Purchase this report to view the information.

6.5%

Subsidiaries

Eone Diagnomics Genome Center Asia

100%

Eone Diagnomics Genome Center Inc

100%

이디지씨헬스케어(주)

48.93%

Company Performance

Financial values in the chart are available after Eone Diagnomics Genome Center Co.,Ltd. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

-75.47%▼

Total operating revenue

-44.72%▼

Operating Profit/Loss (EBIT)

N/A

EBITDA

N/A

Net Profit/Loss for the Period

N/A

Total Assets

-61.15%▼

Total Equity

-83.16%▼

Operating Profit Margin (ROS)

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Debt/Equity

295.68%▲

Quick Ratio

0.18%▲

Cash Ratio

0.18%▲

Eone Diagnomics Genome Center Co.,Ltd. (South Korea)

Similar companies